L. Baboci

Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients

C. Plass, T. Hielscher, M. Pawlita, 2016, Epigenetics.

A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine Learning

David L. Gibbs, C. Furlanello, M. Chierici, 2019, Cancers.

Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16‐driven oropharyngeal squamous cell carcinoma

M. Wiesenfarth, M. Pawlita, C. Herold-Mende, 2017, International journal of cancer.

Loss of Spry1 reduces growth of BRAFV600-mutant cutaneous melanoma and improves response to targeted therapy

A. Weisz, M. Maio, L. Baboci, 2020, Cell Death & Disease.

Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: A retrospective multicentre study.

L. Alemany, X. Castellsagué, M. Wiesenfarth, 2017, European journal of cancer.

Oral Human Papillomavirus and Human Herpesvirus-8 Infections Among Human Immunodeficiency Virus Type 1–Infected Men and Women in Italy

A. Del Mistro, L. Baboci, A. Cattelan, 2012, Sexually transmitted diseases.

Long-Term Clinical Outcome after Treatment for High-Grade Cervical Lesions: A Retrospective Monoinstitutional Cohort Study

M. Zorzi, A. Del Mistro, L. Baboci, 2015, BioMed research international.

Use of a high‐risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population‐based cohort study

M. Zorzi, A. Del Mistro, M. Gennaro, 2013, BJOG : an international journal of obstetrics and gynaecology.